19.52
Schlusskurs vom Vortag:
$18.76
Offen:
$19.19
24-Stunden-Volumen:
904.11K
Relative Volume:
0.91
Marktkapitalisierung:
$946.01M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-7.2565
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+14.89%
1M Leistung:
+37.66%
6M Leistung:
-22.04%
1J Leistung:
+26.59%
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CDNA
Caredx Inc
|
19.52 | 946.01M | 312.78M | -143.56M | 1.22M | -2.69 |
![]()
TMO
Thermo Fisher Scientific Inc
|
401.90 | 152.06B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
196.02 | 135.91B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
524.91 | 41.29B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
115.80 | 31.79B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
152.32 | 24.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
2022-04-25 | Eingeleitet | Stephens | Overweight |
2021-07-20 | Fortgesetzt | BTIG Research | Buy |
2021-06-03 | Eingeleitet | Goldman | Buy |
2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
2020-06-26 | Eingeleitet | BTIG Research | Buy |
2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2019-02-15 | Eingeleitet | Jefferies | Buy |
2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
2016-06-14 | Bestätigt | Mizuho | Buy |
2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2015-09-25 | Eingeleitet | Craig Hallum | Buy |
2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx at Jefferies Global Healthcare: Strategic Growth and Market Focus - Investing.com
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire
CareDx, Inc (NASDAQ:CDNA) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
CareDx Inc (CDNA) Shares Up 9.75% on Jun 4 - GuruFocus
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Established in Securities Fraud Class Action - ACCESS Newswire
CareDx announces new $50 million stock buyback program - Investing.com India
CareDx Announces New $50 Million Stock Repurchase - TipRanks
CareDx (CDNA) Announces New $50M Share Repurchase Program - GuruFocus
CareDx Launches New $50 Million Share Buyback Plan - marketscreener.com
CareDx authorizes new repurchase of up to $50M of shares - TipRanks
CareDx (CDNA) Completes $50M Stock Buyback and Plans Further Repurchase | CDNA Stock News - GuruFocus
CareDx Announces Repurchase of 5% of Outstanding Shares | CDNA Stock News - GuruFocus
CareDx Announces Repurchase Of 5% Of Outstanding Shares - marketscreener.com
CareDx Announces Repurchase of 5% of Outstanding Shares - The Joplin Globe
Caredx Insider Sold Shares Worth $523,413, According to a Recent SEC Filing - marketscreener.com
Tidal Investments LLC Trims Stock Holdings in CareDx, Inc (NASDAQ:CDNA) - Defense World
Director’s Major Stock Sale Shakes Up CareDx! - TipRanks
CareDx Inc (CDNA) Stock Price Down 5.58% on May 29 - GuruFocus
Nuveen Asset Management LLC Boosts Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
Ameriprise Financial Inc. Buys 38,101 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - Business Wire
Deutsche Bank AG Sells 23,401 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders - GlobeNewswire Inc.
CareDx, Inc (NASDAQ:CDNA) Shares Acquired by BNP Paribas Financial Markets - Defense World
Northern Trust Corp Buys 33,788 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
Learn to Evaluate (CDNA) using the Charts - news.stocktradersdaily.com
CareDx (NASDAQ:CDNA) Trading 5.8% Higher – Here’s What Happened - Defense World
CareDx Inc (CDNA) Trading 8.51% Higher on May 16 - GuruFocus
CareDx Agrees to Pay Settlement to $CDNA Investors — Here’s How to Get Your Share - TradingView
Transplantation Market Growth, Trends & Forecast 2025 | Top key playersCareDx, Inc., Hologic, Inc, QIAGEN. - openPR.com
Major Stock Sale by CareDx Director Revealed! - TipRanks
CareDx to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph
Price T Rowe Associates Inc. MD Has $581,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World
CareDx Secures Speaking Slots at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
CareDx, Inc (NASDAQ:CDNA) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Dimensional Fund Advisors LP Sells 7,853 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World
HC Wainwright Analysts Lift Earnings Estimates for CareDx - Defense World
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Christine Cournoyer Sells 16,700 Shares of CareDx Inc (CDNA) - GuruFocus
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
CareDx’s (CDNA) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | - GuruFocus
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | CDNA Stock News - GuruFocus
Analyst Expectations For CareDx's Future - Benzinga
CareDx (CDNA) Stock Rating and Price Target Update | CDNA Stock News - GuruFocus
CareDx outlines $365M-$375M 2025 revenue target while advancing transplant solutions - MSN
CareDx, Inc (NASDAQ:CDNA) Shares Purchased by Wells Fargo & Company MN - Defense World
CDNA 7/22/22 DEADLINE: Lieff Cabraser Urges CareDx Investors to Contact Us About Pending Securities Fraud Action - ACCESS Newswire
Insider Sell: Peter Maag Sells 13,281 Shares of CareDx Inc (CDNA) - GuruFocus
Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation? - simplywall.st
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):